New study aims to find best way to stop arthritis drug without relapse
NCT ID NCT06037460
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 37 times
Summary
This study looks at 120 people with giant cell arteritis (a type of blood vessel inflammation) who are stable on tocilizumab. Researchers want to see if gradually reducing the drug is better than stopping it all at once to prevent the disease from flaring up. The goal is to find a safer, more effective way to stop treatment while keeping patients healthy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France
Conditions
Explore the condition pages connected to this study.